Immunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelination.
Saved in:
| Title: | Immunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelination. |
|---|---|
| Authors: | Badawi GA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Sinai University-Arish Branch, Arish, 45511, Egypt., El-Sayed RM; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Sinai University-Arish Branch, Arish, 45511, Egypt., Fawzy MN; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Sinai University-Arish Branch, Arish, 45511, Egypt. mohamed.naser@su.edu.eg. |
| Source: | Inflammopharmacology [Inflammopharmacology] 2026 Jul 28. Date of Electronic Publication: 2026 Jul 28. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9112626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1568-5608 (Electronic) Linking ISSN: 09254692 NLM ISO Abbreviation: Inflammopharmacology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1568-5608 |
|---|---|
| DOI: | 10.1007/s10787-026-02350-y |
